Skip to content

Hypopressive Exercise Associated With Strength and Resistance Training in Women Treated for Gynecological Cancer

Effects of Hypopressive Exercise Associated With Strength and Resistance Training in the Management of Fatigue, Urinary Incontinence Symptoms, Sexual Function and Quality of Life in Women Treated for Gynecological Cancer

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05493319
Enrollment
36
Registered
2022-08-09
Start date
2023-03-01
Completion date
2023-07-30
Last updated
2022-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic Cancer

Keywords

Exercise Therapy, Neoplasms, Fatigue, Quality of Life, Urinary Incontinence

Brief summary

The study aims to evaluate the effects of 4 weeks of hypopressive exercise associated with resistance training and aerobic exercises on fatigue, symptoms of urinary incontinence, sexual function and quality of life in women treated for gynecological cancer compared to a group that will perform conventional training. .

Detailed description

Objective: To evaluate the effects of 4 weeks of hypopressive exercise associated with resistance training and aerobic exercises on fatigue, symptoms of urinary incontinence, sexual function and quality of life in women treated for gynecological cancer compared to a group that will perform conventional training. Methods: This will be a single-blind randomized clinical trial. A hypopressive exercise intervention associated with resistance training and aerobic exercise will be carried out during twelve telerehabilitation sessions. Patients over 18 years of age who are diagnosed with gynecological cancer and who are indicated for radiotherapy or chemotherapy will participate. Patients will be randomly assigned to an experimental group of hypopressive exercises associated with resistance training and aerobic exercises or conventional training. Fatigue, quality of life, symptoms of urinary incontinence and sexual function will be evaluated before and after the intervention. Discussion: The results of this clinical trial will determine the impact of conventional training associated with hypopressive exercise on the negative side effects of cancer treatment in women with gynecological cancer.

Interventions

OTHERExercises

Both groups will train three times a week, twice synchronously online and once asynchronously, considering a standardized exercise guideline. In all intervention sessions, conventional exercises will be guided by the standardized exercise guideline previously developed by the study team, for 4 weeks. Hypopresive, strength and resistance exercises group will receive static hypopressive exercise in supine position, with variant of arms in flexion, abduction and extension, consisting of 3 exercises at the end of the intervention with strength and resistance exercises.

Sponsors

Universidade Federal de Sao Carlos
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Masking description

Outcome assessments before and after the intervention will be performed by a physical therapist blinded to the allocation of participants in each group.

Intervention model description

Single-blind randomized clinical trial: interventional group and usual care group

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Candidates must have a medical diagnosis of gynecological cancer * Participants should have an indication for chemotherapy or radiotherapy, associated or not with pelvic lymphadenectomy * Women with an age range over 18 years with a limit of up to 60 years * Participants who are able to practice physical activity

Exclusion criteria

* Recurrence of gynecological cancer * Presence of lymphedema in the lower limb, measured by cytometry of the lower limb with a tape measure; asymmetries of more than 2 cm between the limbs were considered edema * Diagnosis of metastasis * Heart disease

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline at 4 weeks in quality of life assessed by a questionnaireBaseline/up to 4 weeksData are be collected using the questionnaire The European Organization for Research and Treatment of Cancer Core Quality of Life questionnaire it contains 30 items and the total score ranges from 0 (very poor) to 100 (excellent) for the functional dimensions, and from 0 (excellent) to 100 (very poor) for the symptom dimensions. All of the multi-item scales and single-item measures range in a score from 0 to 100, where a high score represents a higher response level.
Change from baseline at 4 weeks in sexual function assessed by a questionnaireBaseline/up to 4 weeksData are be collected using the questionnaire Organ Prolapse/Urinary Incontinence Sexual Questionnaire that consists of 12 items, the scores range from 0 to 48, the higher the score, the better the sexual function.
Change from baseline at 4 weeks in urinary incontinence assessed by a questionnaireBaseline/up to 4 weeksData are be collected using the questionnaire Pelvic Floor Impact Questionnaire-Short Form 7 that score corresponds to 0: not at all; 1: something; 2: moderately and 3: quite a bit. For the conversion of the score, the mean score must be multiplied with 100/3 and a scale range of 0 to 100 is obtained, the higher the score, the greater the impact of symptoms on general activities.
Change from baseline at 4 weeks in fatigue assessed by a scaleBaseline/up to 4 weeksData are be collected using the scale the Brief Fatigue Inventory that it is made up of 3 items, the categorization of fatigue levels can be obtained through an arithmetic average of the scores obtained in each item. Score 0 means no fatigue; 1-3: mild fatigue; 4-6: moderate fatigue and 7-10: severe fatigue.

Countries

Chile

Contacts

Primary ContactIvana L Ribeiro, PhD
ivanaleao@gmail.com+56 712413622

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026